US 6919347
Bradykinin B1 receptor antagonists
expired A61PA61P1/02A61P1/16
Quick answer
US patent 6919347 (Bradykinin B1 receptor antagonists) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 64
- CPC classes
- A61P, A61P1/02, A61P1/16, A61P11/02, A61P11/06